Non-vision adverse events with vigabatrin therapy
نویسندگان
چکیده
منابع مشابه
Visual field defects associated with vigabatrin therapy.
OBJECTIVE To estimate the prevalence of visual field defects in patients taking the anticonvulsant drug vigabatrin and to characterise the features of visual dysfunction found. METHODS Thirty three unselected patients attending neurology and epilepsy clinics were identified as taking vigabatrin and asked to attend for neuro-ophthalmic evaluation. A control group of 16 patients with epilepsy u...
متن کاملNondermatologic adverse events associated with anti-EGFR therapy.
Dermatologic events are considered the most relevant elements of the toxicity profile of epidermal growth factor receptor (EGFR) inhibitors. However, some nondermatologic adverse events can also be common. Although these toxicities are rarely severe, they may have fatal outcomes if not managed appropriately. For example, gefitinib (Iressa) and erlotinib (Tarceva) (and more rarely, cetuximab [Er...
متن کاملAdverse events associated with ERCP.
Vinay Chandrasekhara, MD, Mouen A. Khashab, MD, V. Raman Muthusamy, MD, FASGE, Ruben D. Acosta, MD, Deepak Agrawal, MD, MPH, David H. Bruining, MD, Mohamad A. Eloubeidi, MD, MHS, FASGE, Robert D. Fanelli, MD, FACS, FASGE, SAGES Representative, Ashley L. Faulx, MD, FASGE, Suryakanth R. Gurudu, MD, FASGE, Shivangi Kothari, MD, Jenifer R. Lightdale, MD, MPH, FASGE, NASPGHAN Representative, Bashar ...
متن کاملMonitoring for adverse events among patients on tuberculosis therapy.
In Australia, patients with diagnosed or clinically suspected TB are treated under the guidance of a specialist with training in TB management. Standard therapy for TB follows international and Australian guidelines and traditionally involves an intensive phase of drug therapy followed by a continuation phase. The majority of treatment – with only rare exceptions – is administered by directly o...
متن کاملAdverse cardiac events to monoclonal antibodies used for cancer therapy
Monoclonal antibodies are currently used in the treatment of neoplastic, hematological, or inflammatory diseases, a practice that is occasionally associated with a variety of systemic and cutaneous adverse events. Cardiac adverse events include cardiomyopathy, ventricular dysfunction, arrhythmias, arrests, and acute coronary syndromes, such as acute myocardial infarction and vasospastic angina ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Neurologica Scandinavica
سال: 2011
ISSN: 0001-6314
DOI: 10.1111/j.1600-0404.2011.01602.x